Madrigal Pharmaceuticals, Inc. (MDGL)
540.03
+6.27
(+1.17%)
USD |
NASDAQ |
Aug 31, 16:00
538.90
-1.13
(-0.21%)
After-Hours: 20:00
Madrigal Pharmaceuticals Cash and Short Term Investments (Quarterly) : 838.91M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 838.91M |
| March 31, 2026 | 817.93M |
| December 31, 2025 | 988.65M |
| September 30, 2025 | 1.115B |
| June 30, 2025 | 802.02M |
| March 31, 2025 | 848.07M |
| December 31, 2024 | 931.25M |
| September 30, 2024 | 1.004B |
| June 30, 2024 | 1.063B |
| March 31, 2024 | 1.059B |
| December 31, 2023 | 634.13M |
| September 30, 2023 | 232.35M |
| June 30, 2023 | 298.42M |
| March 31, 2023 | 329.48M |
| December 31, 2022 | 358.77M |
| September 30, 2022 | 153.19M |
| June 30, 2022 | 211.77M |
| March 31, 2022 | 219.95M |
| December 31, 2021 | 270.35M |
| September 30, 2021 | 299.14M |
| June 30, 2021 | 323.85M |
| March 31, 2021 | 307.22M |
| December 31, 2020 | 284.15M |
| September 30, 2020 | 335.94M |
| June 30, 2020 | 384.38M |
| Date | Value |
|---|---|
| March 31, 2020 | 408.51M |
| December 31, 2019 | 439.04M |
| September 30, 2019 | 453.61M |
| June 30, 2019 | 466.40M |
| March 31, 2019 | 477.82M |
| December 31, 2018 | 483.72M |
| September 30, 2018 | 488.54M |
| June 30, 2018 | 490.30M |
| March 31, 2018 | 182.82M |
| December 31, 2017 | 191.53M |
| September 30, 2017 | 62.14M |
| June 30, 2017 | 67.17M |
| March 31, 2017 | 40.13M |
| December 31, 2016 | 40.50M |
| September 30, 2016 | 39.56M |
| June 30, 2016 | 43.02M |
| March 31, 2016 | 52.04M |
| December 31, 2015 | 0.3062M |
| September 30, 2015 | 88.25M |
| June 30, 2015 | 98.33M |
| March 31, 2015 | 76.61M |
| December 31, 2014 | 97.69M |
| September 30, 2014 | 119.28M |
| June 30, 2014 | 112.06M |
| March 31, 2014 | 78.79M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Exelixis, Inc. | 839.38M |
| Karyopharm Therapeutics, Inc. | 65.10M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |